ThanesJasonVanigMD

Infectious Disease • Phoenix, AZ

Physician

Join to view full profile

Dr. Vanig is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vanig's full profile

Already have an account?

Office
52 E Monterey Way
Phoenix, AZ 85012
Phone+1 602-604-9500

Fax+1 602-631-9303

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 1991 - 1992
Mount Auburn HospitalResidency, Internal Medicine, 1988 - 1991
Mahidol University Faculty of MedicineClass of 1985

Certifications & Licensure

CA State Medical License 1995 - Present
AZ State Medical License 1996 - 2026
AL State Medical License 1992 - 1995

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Solution Series EHR, e-MDs, 2011

Publications & Presentations

PubMed

8 citations
96-Week Results of a Pilot Study of Abacavir/Lamivudine and Raltegravir in Antiretroviral-Naïve HIV-1–Infected Patients: The SHIELD Trial
Benjamin Young, Thanes Vanig, Edwin DeJesus, Trevor Hawkins, M H St Clair
HIV Clinical Trials. 2011-07-01
5 citations
Self-examination behaviors for syphilis symptoms among HIV-infected men.
Melanie M. Taylor, Brandy Peterson, John Post, Carol Williams, Thanes Vanig
Journal of Acquired Immune Deficiency Syndromes. 2010-10-01
20 citations
A Pilot Study of Abacavir/Lamivudine and Raltegravir in Antiretroviral-Naïve HIV-1–Infected Patients: 48-Week Results of the SHIELD Trial
Benjamin Young, Thanes Vanig, Edwin DeJesus, Trevor Hawkins, Marty St. Clair
HIV Clinical Trials. 2010-09-01

Press Mentions

HIV Is up in Arizona, yet AHCCCS Doesn't Cover the Drugs Many Patients NeedJanuary 30th, 2021